Close Menu
NEW YORK (GenomeWeb News) — CXR Biosciences has licensed Rosetta Biosoftware’s Resolver system, the companies said today.
 
CXR, a Dundee, Scotland-based drug developer, said it will use the software to determine the toxicological profiles of early-stage compounds in drug -toxicity studies.
 
Financial terms of the deal were not released.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

New US Department of Commerce rules will affect supercomputing in China, according to the Wall Street Journal.

A new analysis finds that it will be more than a century until female computer scientists publish at the same rate as their male counterparts, ScienceInsider reports.

Broad Institute researchers describe an approach they've dubbed "DNA microscopy."

In PLOS this week: epigenetic changes following hepatitis C virus treatment, metagenomic analysis of Ugandan children with febrile illness, and more.